Quarterly report pursuant to Section 13 or 15(d)

Goodwill and In-process R&D (Details)

v3.20.2
Goodwill and In-process R&D (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2017
Dec. 31, 2019
Goodwill and In-Process R&D            
Goodwill $ 1,452,338   $ 1,452,338     $ 1,452,338
Goodwill Gross           2,200,000
Goodwill, Fair Value           1,500,000
Goodwill impairment loss $ 0 $ (737,000) $ 0 $ (737,000)    
Impairment loss           $ 700,000
Pelican Therapeutics, Inc.            
Goodwill and In-Process R&D            
Goodwill         $ 2,200,000  
In-process R&D         $ 5,900,000